Recent Posts
- Canady Helios Cold Plasma Induces Non-Thermal (24 °C), Non-Contact Irreversible Electroporation and Selective Tumor Cell Death at Surgical Margins
- Canady Helios Cold Plasma Induces Non-Thermal (24 °C), Non-Contact Irreversible Electroporation and Selective Tumor Cell Death at Surgical Margins
- US Medical Innovations Secures FDA Clearance for Canady Helios Cold Plasma™ Ablation System
- USMI TO DEBUT THE CANADY ROBOTIC AI SURGICAL SYSTEM AT THE FIRST GLOBAL SURGICAL ONCOLOGY SUMMIT JERUSALEM, ISRAEL JANUARY 2024
- Groundbreaking Results Using Canady Helios™ Cold Plasma Treatment Published in MDPI Journal “Cancers”
Recent Comments
No comments to show.
